• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

红景天苷,一种源自人参的外源性溶血磷脂酸受体配体,可增强血脑屏障通透性和脑内递药。

Gintonin, a ginseng-derived exogenous lysophosphatidic acid receptor ligand, enhances blood-brain barrier permeability and brain delivery.

机构信息

Neurovascular Biology Laboratory, Department of Structure and Function of Neural Network, Korea Brain Research Institute, Daegu 41068, Republic of Korea.

Department of Convergence Medical Science, Brain Korea 21 Plus Program, and Institute of Korean Medicine, College of Korean Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.

出版信息

Int J Biol Macromol. 2018 Jul 15;114:1325-1337. doi: 10.1016/j.ijbiomac.2018.03.158. Epub 2018 Mar 29.

DOI:10.1016/j.ijbiomac.2018.03.158
PMID:29604355
Abstract

Gintonin is a ginseng-derived G-protein-coupled lysophosphatidic acid (LPA) receptor ligand. Gintonin induces [Ca] transient and biological effects through LPA receptor and increases the permeability of the blood-brain barrier (BBB). However, little is known about its mechanisms on the BBB. We examined the in vitro effects of gintonin using primary human brain microvascular endothelial cells (HBMECs) and the in vivo effects of gintonin on brain delivery. Fluorescent-labeled gintonin bound to HBMECs and co-localized with the LPA1 receptor. Gintonin caused morphological changes, increased junctional spaces, and induced differential effects on junctional protein levels such as vascular endothelial-cadherin, occludin, zonula occludens 1, and claudin-5, in HBMECs. Gintonin led to the opening of gap junctions between HBMECs, and allowed Texas red-dextran to enter the cells, which was blocked by Ki16425, an LPA1/3 receptor antagonist, and Y27632, a Rho-associated kinase inhibitor. Intravenous administration of gintonin in rodents also increased the delivery of fluorescein isothiocyanate-dextran or erythropoietin to the brain. Furthermore, fluorescent-labeled gintonin bound to endothelial cells, neurons, and glia in the brain following its entry. Our findings show that gintonin facilitates entry to the brain through the paracellular pathway. Thus, gintonin may be an herbal medicine-derived candidate to overcome the BBB in drug delivery.

摘要

金雀异黄素是一种源自人参的 G 蛋白偶联溶血磷脂酸(LPA)受体配体。金雀异黄素通过 LPA 受体诱导 [Ca]瞬变和生物学效应,并增加血脑屏障(BBB)的通透性。然而,其对 BBB 的作用机制知之甚少。我们使用原代人脑微血管内皮细胞(HBMEC)研究了金雀异黄素的体外作用,以及金雀异黄素对脑内给药的体内作用。荧光标记的金雀异黄素与 HBMEC 结合,并与 LPA1 受体共定位。金雀异黄素引起 HBMEC 的形态变化,增加了连接间隙,并诱导连接蛋白水平的差异效应,如血管内皮钙黏蛋白、occludin、zonula occludens 1 和 claudin-5。金雀异黄素导致 HBMEC 之间的缝隙连接开放,并允许 Texas red-dextran 进入细胞,这被 LPA1/3 受体拮抗剂 Ki16425 和 Rho 相关激酶抑制剂 Y27632 阻断。在啮齿动物中静脉给予金雀异黄素也增加了荧光素异硫氰酸酯右旋糖酐或促红细胞生成素向脑内的传递。此外,进入大脑后,荧光标记的金雀异黄素与内皮细胞、神经元和神经胶质结合。我们的研究结果表明,金雀异黄素通过细胞旁途径促进进入大脑。因此,金雀异黄素可能是一种草药衍生的候选药物,可用于克服药物输送中的 BBB。

相似文献

1
Gintonin, a ginseng-derived exogenous lysophosphatidic acid receptor ligand, enhances blood-brain barrier permeability and brain delivery.红景天苷,一种源自人参的外源性溶血磷脂酸受体配体,可增强血脑屏障通透性和脑内递药。
Int J Biol Macromol. 2018 Jul 15;114:1325-1337. doi: 10.1016/j.ijbiomac.2018.03.158. Epub 2018 Mar 29.
2
Gintonin, a novel ginseng-derived lysophosphatidic acid receptor ligand, stimulates neurotransmitter release.人参皂草苷,一种新型的源自人参的溶血磷脂酸受体配体,可刺激神经递质释放。
Neurosci Lett. 2015 Jan 1;584:356-61. doi: 10.1016/j.neulet.2014.11.007. Epub 2014 Nov 11.
3
Gintonin influences the morphology and motility of adult brain neurons via LPA receptors.人参炔醇通过溶血磷脂酸(LPA)受体影响成体脑神经元的形态和运动性。
J Ginseng Res. 2021 May;45(3):401-407. doi: 10.1016/j.jgr.2020.06.003. Epub 2020 Jul 21.
4
Gintonin stimulates gliotransmitter release in cortical primary astrocytes.人参炔三醇刺激皮质原代星形胶质细胞释放神经胶质递质。
Neurosci Lett. 2015 Aug 31;603:19-24. doi: 10.1016/j.neulet.2015.07.012. Epub 2015 Jul 17.
5
Activation of lysophosphatidic acid receptor by gintonin inhibits Kv1.2 channel activity: involvement of tyrosine kinase and receptor protein tyrosine phosphatase α.金雀异黄素通过激活溶血磷脂酸受体抑制 Kv1.2 通道活性:涉及酪氨酸激酶和受体蛋白酪氨酸磷酸酶 α。
Neurosci Lett. 2013 Aug 26;548:143-8. doi: 10.1016/j.neulet.2013.05.048. Epub 2013 Jun 12.
6
Gintonin facilitates brain delivery of donepezil, a therapeutic drug for Alzheimer disease, through lysophosphatidic acid 1/3 and vascular endothelial growth factor receptors.人参皂苷Rb1通过溶血磷脂酸1/3和血管内皮生长因子受体促进多奈哌齐(一种治疗阿尔茨海默病的药物)进入大脑。
J Ginseng Res. 2021 Mar;45(2):264-272. doi: 10.1016/j.jgr.2019.12.002. Epub 2019 Dec 16.
7
Gintonin, a Ginseng-Derived Exogenous Lysophosphatidic Acid Receptor Ligand, Protects Astrocytes from Hypoxic and Re-oxygenation Stresses Through Stimulation of Astrocytic Glycogenolysis.Gintonin,一种源自人参的外源性溶血磷脂酸受体配体,通过刺激星形胶质细胞糖酵解来保护星形胶质细胞免受缺氧和再复氧应激。
Mol Neurobiol. 2019 May;56(5):3280-3294. doi: 10.1007/s12035-018-1308-1. Epub 2018 Aug 16.
8
Gintonin: a novel ginseng-derived ligand that targets G protein- coupled lysophosphatidic acid receptors.红景天苷:一种新型的人参衍生配体,靶向 G 蛋白偶联溶血磷脂酸受体。
Curr Drug Targets. 2012 Dec;13(13):1659-64. doi: 10.2174/138945012803529947.
9
Gintonin, a ginseng-derived novel ingredient, evokes long-term potentiation through N-methyl-D-aspartic acid receptor activation: involvement of LPA receptors.红景天苷,一种源自人参的新型成分,通过 N-甲基-D-天冬氨酸受体激活引发长时程增强:涉及 LPA 受体。
Mol Cells. 2012 Dec;34(6):563-72. doi: 10.1007/s10059-012-0254-4. Epub 2012 Nov 15.
10
Gintonin, newly identified compounds from ginseng, is novel lysophosphatidic acids-protein complexes and activates G protein-coupled lysophosphatidic acid receptors with high affinity.Gintonin 是从人参中新发现的化合物,是新型溶血磷脂酸-蛋白复合物,能以高亲和力激活 G 蛋白偶联的溶血磷脂酸受体。
Mol Cells. 2012 Feb;33(2):151-62. doi: 10.1007/s10059-012-2216-z.

引用本文的文献

1
Ginseng Nanosizing: The Second Spring of Ginseng Therapeutic Applications.人参纳米化:人参治疗应用的又一春天。
Antioxidants (Basel). 2025 Aug 5;14(8):961. doi: 10.3390/antiox14080961.
2
Phased blood-brain barrier disruption in ischaemic stroke: implications for therapy?缺血性卒中的阶段性血脑屏障破坏:对治疗有何影响?
Fluids Barriers CNS. 2025 Aug 27;22(1):90. doi: 10.1186/s12987-025-00701-5.
3
Unraveling the Role of Autotaxin and Lysophosphatidic Acid in Alzheimer's Disease: From Molecular Mechanisms to Therapeutic Potential.
解析自分泌运动因子和溶血磷脂酸在阿尔茨海默病中的作用:从分子机制到治疗潜力
Int J Mol Sci. 2025 Jul 23;26(15):7068. doi: 10.3390/ijms26157068.
4
Gintonin Binds to Reduced LPA4 Receptor Subtype in Human Cortical Neurons in Alzheimer's Disease Brains.人参炔醇与阿尔茨海默病大脑中人类皮质神经元中失活的LPA4受体亚型结合。
Biomolecules. 2025 Jan 26;15(2):179. doi: 10.3390/biom15020179.
5
Engineering extracellular vesicles to transiently permeabilize the blood-brain barrier.工程化细胞外囊泡以瞬时通透血脑屏障。
J Nanobiotechnology. 2024 Dec 2;22(1):747. doi: 10.1186/s12951-024-03019-w.
6
Emerging evidence that ginseng components improve cognition in subjective memory impairment, mild cognitive impairment, and early Alzheimer's disease dementia.新出现的证据表明,人参成分可改善主观记忆障碍、轻度认知障碍和早期阿尔茨海默病痴呆症患者的认知能力。
J Ginseng Res. 2024 May;48(3):245-252. doi: 10.1016/j.jgr.2024.02.002. Epub 2024 Feb 17.
7
Brain plasticity and ginseng.大脑可塑性与人参。
J Ginseng Res. 2024 May;48(3):286-297. doi: 10.1016/j.jgr.2024.03.007. Epub 2024 Mar 26.
8
Blood-Brain Barrier Disruption for the Treatment of Primary Brain Tumors: Advances in the Past Half-Decade.血脑屏障破坏在原发性脑肿瘤治疗中的应用:过去五年的进展。
Curr Oncol Rep. 2024 Mar;26(3):236-249. doi: 10.1007/s11912-024-01497-7. Epub 2024 Feb 8.
9
Active Compounds of in the Improvement of Alzheimer's Disease and Application of Spatial Metabolomics.[某种物质]的活性成分在阿尔茨海默病改善中的作用及空间代谢组学的应用
Pharmaceuticals (Basel). 2023 Dec 26;17(1):38. doi: 10.3390/ph17010038.
10
Atypical formations of gintonin lysophosphatidic acids as new materials and their beneficial effects on degenerative diseases.人参皂苷溶血磷脂酸的非典型形式作为新材料及其对退行性疾病的有益作用。
J Ginseng Res. 2024 Jan;48(1):1-11. doi: 10.1016/j.jgr.2023.02.004. Epub 2023 Feb 21.